Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn’s Disease: A Systematic Review
Clinical Gastroenterology and Hepatology · 2026-04 · 24 (4) · 932-948
DOI: 10.1016/j.cgh.2025.03.024 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-04. Verfasst von Nathaniel A Cohen und 35 weiteren Autor:innen. Beteiligte Einrichtung: IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, affiliated with the Faculty of Medical and Health Sc…. Hauptthemen laut MEDLINE: Crohn Disease, Upper Gastrointestinal Tract. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND & AIMS: The diagnosis and management of ileocolonic Crohn's disease are well-established. In contrast, standardized guidance pertaining to the diagnosis and management of upper gastrointestinal Crohn's disease (UGICD) is lacking, despite its potentially severe consequences. This comprehensive systematic review describes the prevalence, clinical presentation, and medical and surgical management of involvement of the upper GI tract in adult patients with Crohn's disease. METHODS: A systematic review of available literature was conducted using the search engines Medline, Cochrane, and Embase, with pre-defined search algorithms. Studies published from 1947 to July 2024 were considered. The review included papers describing both clinical characteristics and the effectiveness of medical and interventional procedures in patients with UGICD. All included papers underwent quality appraisal using the Joanna Briggs Institute checklist. RESULTS: Following screening and full-text review, 47 articles were eligible. The median prevalence of UGICD was found to be 8.7% (interquartile range, 4.74%-24.36%). Over one-third of patients with UGICD are asymptomatic, and abdominal pain was the most frequently reported symptom in symptomatic patients (41%; range, 5%-93%). Endoscopy is the most used diagnostic tool (96%), with the duodenum being the most common disease location (69%). Accepted definitions of UGICD within each diagnostic modality have not been devised. Anti-tumor necrosis factor therapy appears to be efficacious for UGICD (overall clinical response, 81%). The current data are limited by the significant heterogeneity in study design and definitions between studies, particularly inconsistency in diagnosis and outcome measures used. CONCLUSIONS: We highlight the need for the development of standardized guidance in both diagnosing and managing UGICD. This work serves as preparation for an international consensus on the management of UGICD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, affiliated with the Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: nat…
- Department of Internal Medicine B, Tel Aviv Sourasky Medical Center, affiliated with the School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Gastroenterology, Hepatology and Nutrition; Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio.
- CED Schwerpunktpraxis Münster, Münster, Germany and Medical Faculty, University of Münster, Münster Germany.
- Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
- Digestive Disease and Surgery Institute Clinical Research Unit, Cleveland Clinic, Cleveland, Ohio.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Cohen, N. A., Sror, N., Naseer, M., Bettenworth, D., Lu, C., Khedraki, R., Abreu, M. T., Atreya, R., Al-Bawardy, B., Connor, S. J., d'Haens, G., Dotan, I., Dignass, A., El Ouali, S., Feagan, B., Feakins, R., Gearry, R., Gordon, I. O., Hedin, C., …, & Rieder, F. (2026). Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn’s Disease: A Systematic Review. Clinical Gastroenterology and Hepatology, 24(4), 932-948. https://doi.org/10.1016/j.cgh.2025.03.024
Vancouver
Cohen NA, Sror N, Naseer M, Bettenworth D, Lu C, Khedraki R, et al. Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn’s Disease: A Systematic Review. Clinical Gastroenterology and Hepatology. 2026;24(4):932-948. doi:10.1016/j.cgh.2025.03.024
BibTeX
@article{Cohen2026,
author = {Cohen, Nathaniel A and Sror, Neta and Naseer, Maliha and Bettenworth, Dominik and Lu, Cathy and Khedraki, Raneem and Abreu, Maria T and Atreya, Raja and Al-Bawardy, Badr and Connor, Susan J and d'Haens, Geert and Dotan, Iris and Dignass, Axel and El Ouali, Sara and Feagan, Brian and Feakins, Roger and Gearry, Richard and Gordon, Ilyssa O and Hedin, Charlotte and Kobayashi, Taku and Leibovitzh, Haim and Maharshak, Nitsan and Ollech, Jacob and Sebastian, Shaji and Siegmund, Britta and Rubin, David T and Silverberg, Mark S and Steinwurz, Flavio and Torres, Joana and Watermeyer, Gill and Hernandez-Rocha, Cristian and Gurizzian, Paige and Silfen, Alexa and Tzadok, Roie and Falloon, Katherine and Rieder, Florian},
title = {Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn’s Disease: A Systematic Review},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {4},
pages = {932--948},
doi = {10.1016/j.cgh.2025.03.024}
}
EUVIMED